Next Article in Journal
Heavy Metals and Essential Metals Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease
Next Article in Special Issue
Extracellular Vesicles and Viruses: Two Intertwined Entities
Previous Article in Journal
Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency
Previous Article in Special Issue
Application of Extracellular Vesicles in Allergic Rhinitis: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 1
10.3390/ijms24010466
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration

by
Venkateswaran Ganesh
1,2,†,
Dongrim Seol
1,3,*,†,
Piedad C. Gomez-Contreras
1,
Henry L. Keen
4,
Kyungsup Shin
3 and
James A. Martin
1,2
1
Department of Orthopedics and Rehabilitation, University of Iowa, Iowa City, IA 52242, USA
2
Department of Roy J. Carver Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA
3
Department of Orthodontics, University of Iowa, Iowa City, IA 52242, USA
4
Iowa Institute of Human Genetics, University of Iowa, Iowa City, IA 52242, USA
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(1), 466; https://doi.org/10.3390/ijms24010466
Submission received: 2 November 2022 / Revised: 21 December 2022 / Accepted: 24 December 2022 / Published: 27 December 2022
(This article belongs to the Special Issue Exosomes)
Browse Figures
Review Reports Versions Notes

Abstract

:
Exosomes have attracted attention due to their ability to promote intercellular communication leading to enhanced cell recruitment, lineage-specific differentiation, and tissue regeneration. The object of this study was to determine the effect of exosomes on cell homing and angiogenic differentiation for pulp regeneration. Exosomes (DPSC-Exos) were isolated from rabbit dental pulp stem cells cultured under a growth (Exo-G) or angiogenic differentiation (Exo-A) condition. The characterization of exosomes was confirmed by nanoparticle tracking analysis and an antibody array. DPSC-Exos significantly promoted cell proliferation and migration when treated with 5 × 108/mL exosomes. In gene expression analysis, DPSC-Exos enhanced the expression of angiogenic markers including vascular endothelial growth factor A (VEGFA), Fms-related tyrosine kinase 1 (FLT1), and platelet and endothelial cell adhesion molecule 1 (PECAM1). Moreover, we identified key exosomal microRNAs in Exo-A for cell homing and angiogenesis. In conclusion, the exosome-based cell homing and angiogenic differentiation strategy has significant therapeutic potential for pulp regeneration.

Graphical Abstract

1. Introduction

Dental pulp is a highly vascularized soft tissue with a layer of odontoblasts at the inner dentin surface. One of the main physiological functions of dental pulp is to provide nutrition to dentin and detect unhealthy stimuli as a biosensor. Current endodontic therapy for dental caries, which is one of the most prevalent infectious diseases in the world [1], is a procedure for replacing vital pulp with synthetic materials via root canal therapy (RCT). Calcium hydroxide paste (CHP) and mineral trioxide aggregate (MTA) have been commonly used as pulp-capping materials due to their antibacterial properties, biocompatibility, and reparative dentin bridge formation [2,3,4,5]. However, CHP has several disadvantages for long-term use such as bacterial leakage into the dental pulp, poor cohesive strength, and high solubility [6]. Similarly, the drawbacks of MTA are its expensive cost, discoloration of the tooth, and long setting time [7]. Moreover, RCT-treated pulpless teeth can lose their ability to sense environmental changes and maintain dentin regeneration, ultimately compromising the mechanical integrity of the teeth. As an alternative, vital pulp therapy (VPT), which is defined as a restorative dental treatment that aims to preserve and maintain pulp tissue, is beneficial for young patients who have a high healing capacity for pulp regeneration [8,9]. Recently, the potential for successful VPT and pulp regeneration is increasing due to the use of mesenchymal stem cells (MSCs) that can differentiate into specialized cells [10,11,12]. However, the transplantation of MSCs incurs high costs and risks associated with ex vivo cell expansion [13]. Thus, there is an urgent need to develop alternative therapeutic methodologies for pulp regeneration.
A cell homing strategy is an effective approach for pulp regeneration in endodontics, as it can recruit endogenous dental pulp stem cells (DPSCs) residing in the pulp tissue to the damaged site in need of repair [14]. The DPSCs have unlimited self-renewal with high clonogenicity and lineage-specific multipotent abilities [15,16]. These characteristics empower DPSCs to migrate locally to sites of injury where they proliferate and differentiate as needed to replace damaged tissue [17]. Unlike cell transplantation, this DPSC homing approach does not require multiple surgical procedures for cell harvesting and transplantation.
Exosomes have attracted attention due to their great potential to promote intercellular communication leading to enhanced cell recruitment, differentiation to specific cell lineage, and tissue repair [18,19,20,21,22]. Exosomes represent an important mode of intercellular communication as they contain a variety of bioactive molecules including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), lipids, and proteins [23]. In particular, microRNAs (miRNAs) have been increasingly recognized for their therapeutic potential [24]. Recent studies have demonstrated that damaged tissues are repaired by the paracrine signaling of exosomes rather than direct proliferation and differentiation [25]. This paracrine effect implies that exosome therapy has a clinical advantage over stem cell transplantation in terms of immune response and tumorigenesis. In addition, MSCs are promising sources of exosomes. Recently, exosomes isolated from MSCs have shown therapeutic potential in heart, skin, and hyaline cartilage regeneration [18,21,22,26,27]. More importantly, a series of prior studies have shown DPSC-derived exosome (DPSC-Exo) enhanced cell recruitment and angiogenesis [28,29,30]. In particular, a conditioned medium or exosomes cultured under angiogenic differentiation have great potential for pulp regeneration.
We hypothesized that exosomes isolated from undifferentiated or angiogenic-differentiated DPSCs will play an important role in inducing cell migration and angiogenesis of naïve DPSCs, respectively. The objective of this study was to evaluate the effects of DPSC-Exos on in vitro cell homing and angiogenesis for pulp regeneration.

2. Results

2.1. Characterization of DPSCs and DPSC-Exos

The stem cell characterization of rabbit DPSCs was validated by angiogenic and odontogenic multipotential differentiation. In an endothelial tube formation assay, elongated DPSCs formed capillary-like networks when they were pre-cultured in an angiogenic induction medium (Figure 1B), whereas non-induced cells were clustered together without any tube formation (Figure 1A). In odontogenic differentiation, strong deposits of calcium were observed time-dependently in Alizarin Red S staining (Figure 1C,D).
Exosomes were isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation (Exo-A) condition. The characterization of exosomes was performed by a Nanoparticle Tracking Analyzer (NTA), Exo-CheckTM exosome antibody array, scanning electron microscope (SEM), and cellular uptake assay. The concentration of Exo-G (11.6 × 1010 particles/mL) was approximately two times higher than that of Exo-A (5.5 × 1010 particles/mL), while the mean size of particles was similar (104.3 nm Exo-G and 103.9 nm Exo-A) (Figure 1E). Both Exo-G and Exo-A showed a positive expression of ANXA5, TSG101, FLOT1, ICAM, ALIX, and CD81 as exosome markers, and a negative expression of GM130 as a negative marker (Figure 1F). Under SEM, both exosomes had a spheroid shape approximately 100 nm in size (Figure 1G,H). In an uptake assay, both types of exosomes labeled with PKH67 green fluorescence highly internalized into the DPSCs (Figure 1I,J).

2.2. Effect of DPSC-Exos on Cell Toxicity, Proliferation, Migration, and Angiogenic Differentiation

In the cytotoxicity test, vehicle controls (4.3%, 9.0%, and 16.3% (v/v) phosphate buffered saline (PBS)) did not impact cell viability. Therefore, all data from vehicle controls and no exosome treatment control were pooled together. There was no significant cell death in less than 5 × 108 exosomes. However, the viability was significantly decreased in both 5 × 109 Exo-G (p = 0.003) and Exo-A (p = 0.003) (Figure 2A). For 4 days, 5 × 108 exosome treatments resulted in a slight increase in cell proliferation in both Exo-G (p < 0.001) and Exo-A (p < 0.001) (Figure 2B). In a migration assay using Transwell® plates, exosome treatment with a concentration of 5 × 108 exosomes promoted dramatic cell migration in both groups of Exo-G (p < 0.001) and Exo-A (p < 0.001) (Figure 2C,D). The effect was similar for a positive control which contained 10% (v/v) exosome-depleted FBS. In contrast, a low concentration of exosomes (5 × 107) did not affect cell migration.
To evaluate the effect of DPSC-Exos on angiogenic differentiation, DPSCs were treated with 5 × 108/mL exosomes in basal or complete induction media (bAM or cAM, respectively) for 7 days. There was no effect of DPSC-Exos on the expression of angiogenic markers when cultured in bAM (Figure 3). On the other hand, angiogenic markers of VEGFA, FLT1 (VEGFR1), and PECAM1 were highly expressed when treated with Exo-G and Exo-A in cAM. Both exosome groups showed statistically higher expressions of VEGFA (Exo-G versus control: p < 0.001 and Exo-A versus control: p = 0.004), FLT1 (Exo-G versus control: p < 0.001 and Exo-A versus control: p < 0.001), and PECAM1 (Exo-G versus control: p < 0.001 and Exo-A versus control: p < 0.001). The degree of fold changes between Exo-G and Exo-A was similar in FLT1 and PECAM1, while Exo-G induced a higher expression of VEGFA (p = 0.026 versus Exo-A).

2.3. Exosomal miRNA Profile

In NGS analysis, we found a total of 474 mature and 254 hairpin miRNAs in Exo-G and a total of 459 mature and 253 hairpin miRNAs in Exo-A. Figure 4A,B show highly expressed miRNAs with over 10,000 total read counts in Exo-G and Exo-A, respectively. Mature miRNAs with over 10,000 total read counts in both Exo-G and Exo-A were shown in Figure 4C. In particular, four miRNAs including ocu-miR-199a-3p, ocu-miR-221-3p, ocu-miR-24-3p, and ocu-miR-21-5p were detected in over 100,000 total read counts. In contrast, there was a distinct expression of miRNA levels in Exo-A when compared with that in Exo-G (Figure 4D). Exo-A isolated under angiogenic differentiation conditions included 30 up-regulated (ocu-miR-708-5p, ocu-miR-205-5p, ocu-miR-708-3p, etc.) and 32 down-regulated (ocu-miR-146a-5p, ocu-miR-503-5p, ocu-miR-20b-5p, etc.) mature miRNAs (Figure 4E). There were 18 hairpin miRNAs that significantly changed in Exo-A, of which 9 hairpin miRNAs (ocu-miR-708-5p, ocu-miR-205-5p, ocu-miR-708-3p, etc.) increased and 9 hairpin miRNAs (ocu-miR-708-5p, ocu-miR-205-5p, ocu-miR-708-3p, etc.) decreased. All differentially expressed mature and hairpin miRNAs are listed in Table 1 and Table 2, respectively. Exosomal miRNAs with a significant expression of both mature and hairpin miRNAs in Exo-A were ocu-miR-708 (up), ocu-miR-134 (up), ocu-miR-125b (up), ocu-miR-140 (up), ocu-miR-29b (up), ocu-miR-214 (up), ocu-miR-574 (down), ocu-miR-503 (down), ocu-miR-30a (down), ocu-miR-146a (down), and ocu-miR-671 (down). In addition, 88 and 36 novel miRNAs were identified in Exo-G and Exo-A, respectively (Tables S1 and S2).

3. Discussion

The main objective of this study was to evaluate the therapeutic potential of characterized exosomes to stimulate cell homing and angiogenic differentiation for pulp regeneration. Exosomes were isolated from DPSCs cultured under a growth or angiogenic differentiation condition for Exo-G and Exo-A, respectively. Our results revealed that both DPSC-Exos significantly promoted cell proliferation (Figure 2B), migration (Figure 2C,D), and angiogenic differentiation (Figure 3) when treated with 5 × 108/mL exosomes. In NGS, we profiled miRNAs encapsulated in DPSC-Exos to identify key miRNAs for cell homing and angiogenesis (Figure 4, Table 1 and Table 2).
In this study, DPSC-Exos were isolated by a polymer-based precipitation method which has the advantages of saving time and labor, being easily scalable, and having a higher yield compared to ultracentrifugation [31]. According to a standard guideline from the International Society of Extracellular Vesicles (ISEV) [32], isolated exosomes were characterized in terms of size distribution and concentration, exosome-specific protein markers, morphology, and cellular uptake. In NTA, both DPSC-Exos showed a similar size distribution with a peak at approximately 104 nm, whereas Exo-G had an approximately two-fold enrichment in the concentration compared to Exo-A (Figure 1E). This difference can be explained by different cell types which affect exosome yield. Although there was no direct comparison between DPSCs and angiogenic differentiated DPSCs (or endothelial cells) in the previous study, it is known that MSCs generate a scalable yield of exosomes [33,34]. Exosomes consist of various cargoes, and proteins, especially, in the membrane and cytosol are used for exosome markers. In this study, we validated the exosome compositions including tetraspanins (CD63 and CD81), endosomal sorting complex required for transport (ESCRT) (TSG101 and ALIX), and membrane transport and fusion (ANXA5 and FLOT1) using an antibody array (Figure 1F) [35]. The spheroid morphology of exosomes was confirmed in SEM, and the size distribution (~100 nm) was consistent with the result of NTA (Figure 1G,H). Moreover, exosomes successfully internalized into recipient DPSCs within 48 h of exposure (Figure 1I,J).
The main appeal of our DPSC-Exo-based cell homing strategy lies in their ability to heal by self-congregating at exposure sites. Cell homing or migration, which is a prerequisite process during tissue regeneration, is defined as a directional cell movement in response to chemoattractant and is extremely important in both the development and maintenance of multicellular organisms. Recently, exosomes have been shown to play critical roles in cell migration due to the function of directional sensing, leader-follower behavior, cell adhesion, and extracellular matrix (ECM) degradation [36,37]. Specifically, exosomes contain cyclic adenosine monophosphate (cAMP) that can be actively synthesized and released to promote chemotaxis [38]. Sung and colleagues have reported that migrating cells leave stationary exosome trails to be used as paths for follower cells [39]. In this study, pHluo_M153R-CD63-positive exosome trails were observed behind cells, and following cells exhibited pathfinding behavior on the trails. In addition, cell adhesion molecules, such as integrins and fibronectin highly contained in exosomes, regulate cell migration speed [40]. Lastly, cell migration or invasion is highly achieved by proteolytic ECM degradation to allow for a cell path, and exosomes carry membrane-linked matrix metalloproteinases (MMPs) to promote the invasive motility of cells across ECM [41,42].
Exosomes or conditioned medium cultured from lineage-specific differentiated human bone marrow-derived stromal cells (HMSCs) and DPSCs have a great potential for odontogenesis. Hu and colleagues have shown that exosomes isolated under an odontogenic differentiation condition induced dramatic increases of odontogenic marker genes such as bone morphogenetic protein 9 (BMP9), alkaline phosphatase (ALP), Runt-related transcription factor 2 (RUNX2), and type I collagen [28,43]. In this study, we compared the effects of Exo-A and Exo-G on activities related to tissue regeneration. However, despite differences in miRNA content, there were almost no differences between Exo-G and Exo-A in terms of effects on DPSC proliferation, migration, and angiogenic differentiation. One possible reason for these findings is that proteins carried by both Exo-A and Exo-G were primarily responsible for the observed biologic activities. Moreover, we did not probe for the effects of exosomes on signal transduction pathways, which may have been differentially regulated by Exo-A and Exo-G miRNAs. These hypotheses will be tested in future studies.
Previous studies have reported that the conditioned medium and lysates of human DPSCs promoted angiogenesis by releasing angiogenic factors such as VEGF and monocyte chemotactic protein-1 (MCP-1) [44,45]. Regardless of a similar trend in the results, distinct levels of exosomal miRNA expression were identified in the comparison between Exo-G and Exo-A. Several mature miRNAs (ocu-miR-205-5p [46], ocu-let-7i-3p [47], ocu-miR-874-3p [48], and ocu-miR-29a-3p [47,49,50]) previously shown to be angiogenic were significantly over-represented in Exo-A versus Exo-G (Table 1). In contrast, ocu-miR-503-5p and ocu-miR-20b-5p, which were under-represented in Exo-A compared to Exo-G, may have allowed higher levels of CD40 [51] and hypoxia-inducible factor 1α (HIF-1α) expression [52] in Exo-A treated cultures, which could also lead to greater angiogenic stimulation. In order to further elucidate the difference between Exo-G and Exo-A, we plan to use a partial pulpotomy animal model, which can mimic clinical conditions in humans [53], and the in vivo effect of DPSC-Exos on cell homing and angiogenesis will be evaluated by immunohistochemistry analysis. In addition, the effect of exosomes derived from human DPSCs and the profile of exosomal miRNAs are needed to validate for clinical application.
miRNAs are small non-coding regulatory RNAs and play a role in post-transcriptional regulation of gene expression either by promoting messenger RNA (mRNA) degradation or by blocking the translation of transcribed sequences. Rather than targeting a specific gene, a single miRNA can regulate multiple pathways by modulating more than one Mrna [54]. miRNAs are secreted and transferred to target recipient cells via exosomes, thereby leading to functional cellular changes [55]. In this study, the profiles of miRNAs in DMSC-Exos strongly advocate for their potential in pulp regeneration. Both Exo-G and Exo-A contain mature (over 450), hairpin (over 250), and novel miRNAs (Figure 4, Tables S1 and S2). Among mature miRNA sequences, ocu-miR-199a-3p, ocu-miR-221-3p, ocu-miR-24-3p, and ocu-miR-21-5p were counted in over 100,000 total reads in both exosomes (Figure 4A–C). miR-199a-3p functions as a redundant network of the nitric oxide synthase (NOS)/nitric oxide (NO) pathway, thereby inducting endothelial tubulogenesis and cardiac regeneration [56,57]. The function of miR-221-3p is controversial in terms of angiogenesis. As an anti-angiogenic miRNA, it inhibits cell proliferation and migration in endothelial cells [58]. On the other hand, miR-221 is an essential regulatory node during angiogenesis [59]. Ocu-miR-24-3p exacted from adipose-derived mesenchymal stem cells can accelerate corneal epithelial migration in vitro and in vivo [60]. Lastly, miR-21-5p has a crucial role in regulating cell migration by ECM degradation and promoting angiogenesis via the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) signal pathway [61,62]. Hence, targeting its associated miRNA(s) can serve as a novel therapeutic armamentarium for a given pathophysiologic condition including pulp damage. Once the profiled miRNA candidates are validated through in vivo and in silico modeling, the miRNA sequences can be loaded in engineered exosomes for clinical application, thereby effectively replacing DPSC cultures as a potential means of exosome production.
Most miRNAs are transcribed by RNA polymerase II to generate primary miRNAs (pri-miRNAs), which are then processed into hairpin precursor miRNAs (pre-miRNAs) via Drosha, a type III ribonuclease, resulting in mature miRNAs. In this study, we compared levels of hairpin miRNAs in DPSC-Exos from cells cultured under angiogenic or growth conditions (Exo-A versus Exo-G). A total of 291 hairpin miRNAs were found in DPSC-Exos. Among these, levels of 18 hairpin miRNAs were significantly different in the two groups (Table 2). Seven of these (ocu-miR-708, ocu-miR-134, ocu-miR-125b-2, ocu-miR-140, ocu-miR-29b-1, and ocu-miR-214) were present at significantly higher levels in Exo-A than in Exo-G, and five (ocu-miR-574, ocu-miR-503, ocu-miR-30a, ocu-miR-146a, and ocu-miR-671) were significantly lower in Exo-A versus Exo-G in both mature and hairpin miRNAs. Several of the miRNAs up-regulated in Exo-A have been strongly associated with tissue regeneration. For example, miR-708 was shown to protect against stress-induced apoptosis and promote myocardial regeneration in an animal study of injured hearts [63]. Sun and colleagues have also shown that miR-140-5p regulated DPSC proliferation and differentiation via the toll-like receptor 4 (TLR-4) [64]. Nevertheless, the functions of all listed miRNAs related to pulp regeneration, especially cell migration and angiogenesis, are still unknown. Therefore, further studies are needed to clarify their roles and associated regulatory pathways.
RT-PCR revealed a positive effect of DPSC-Exos on angiogenic marker expression only when angiogenic growth factors (fibroblastic growth factor B, VEGF, insulin-like growth factor-1, and epidermal growth factor) were present in the culture medium (Figure 3). Under these conditions, the expression of the angiogenic markers, VEGFA, FLT1, and PECAM1 was up-regulated up to four-fold by both Exo-G and Exo-A. In contrast, there was no effect of exosomes on cells cultured in basal medium lacking angiogenic growth factors, implying that exosomes may potentiate the effects of these factors. It is unlikely that these effects are attributable solely to exosomal miRNAs because, like MSC-derived exosomes, DPSC exosomes may contain peptide components including VEGF, extracellular matrix metalloproteinase inducer (EMMPRIN), and MMP-9, which play important roles in stimulating angiogenesis [65]. A proteomic analysis will be needed to fully characterize the protein content of DPSC-Exos.

4. Materials and Methods

4.1. Isolation of DPSCs

Two batches of the incisor pulp tissues obtained from New Zealand White rabbit cadavers (approximately 10 months old) were harvested to isolate DPSCs. Under sterile conditions, the dental pulp was minced into approximately 1 mm3 and plated in a culture dish. The tissue fragments and migrated cells were cultured in alpha minimum essential medium (α-MEM; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Thermo Fisher Scientific), 50 µg/mL L-ascorbic acid 2-phosphate trisodium salt (FUJIFILM Wako Chemicals, Richmond, VA, USA), 100 U/mL penicillin-streptomycin (Thermo Fisher Scientific), and 2.5 µg/mL amphotericin B (Sigma-Aldrich, St. Louis, MO, USA) in a hypoxic culture condition (5% O2/CO2 at 37 °C) [66]. Additionally, the cells were cultured in angiogenic differentiation induction media, EGMTM-2 endothelial cell growth medium (Lonza, Bend, OR, USA).

4.2. Characterization of DPSCs

Characterization of DPSCs (3rd–5th passage) was examined by multipotential differentiation. Angiogenic differentiation was evaluated using an endothelial tube formation assay (Cell Biolabs, San Diego, CA, USA) according to the manufacturer’s instructions. In brief, 1.5 × 104 cells cultured in angiogenic induction medium for 10 days were seeded in a 16-well chamber slide (Thermo Fisher Scientific) coated with 50 µL extracellular matrix (ECM) gel. After 4 h, the cells were incubated with 1× Staining solution and imaged by an Olympus FV1000 confocal microscope (Olympus, Center Valley, PA, USA). For odontogenesis, 1.5 × 104 cells were cultured with osteogenic differentiation medium (ScienCell, Carlsbad, CA, USA) in a 6-well plate, and Alizarin Red S staining (Sigma-Aldrich) was used to evaluate the cellular calcium deposit at 10 and 20 days. The cells fixed in 4% formaldehyde were stained with 40 mM Alizarin Red S for 30 min (min) and imaged by an Olympus BX60 microscope (Olympus).

4.3. Isolation of DPSC-Exos

Exosomes were isolated from rabbit DPSCs cultured under a growth (Exo-G) or angiogenic differentiation (Exo-A) condition. For Exo-A isolation, the cells were cultured in an angiogenic differentiation medium for 10 days. The induction medium was replaced with α-MEM growth medium containing 10% exosome-depleted FBS, and the conditioned medium (CM) was collected after 48 h. CM collected from non-inducted DPSCs was prepared for Exo-G isolation. DPSC-Exos were isolated by a precipitation method using ExoQuick-TCTM (System Biosciences, Palo Alto, CA, USA). In brief, CM was centrifuged at 3000 × g for 15 min to remove cells and cell debris. The supernatant was mixed with an ExoQuick-TCTM solution at 4 °C overnight. After centrifugation, the exosome pellet was resuspended in PBS and stored at −80 °C before use.

4.4. Nanoparticle Tracking Analyzer (NTA)

NTA was utilized to obtain the size distribution and concentration of DPSC-Exos using a NanoSight instrument (Malvern Panalytical, Westborough, MA, USA). Exosomes suspended in PBS were placed into a sonic bath at 30 °C for 10 min. The samples were then diluted for analysis with 0.1 µm-filtered PBS and injected into the laser viewing module via an automated syringe pump. The sample was illuminated using project-specific optical configuration settings according to the manufacturer’s protocol. Nanoparticles were tracked individually, counted, and sized via a translational diffusion coefficient. Triple samples were analyzed with the following parameters: syringe flow rate = 13, detection threshold = 3, track length = 10, and camera = 9–15. The data are reported in a number-weighted distribution. Latex beads of 100 nm diameter were used as a reference.

4.5. Exosome Antibody Array

The identification of DPSC-Exos was validated using an Exo-CheckTM exosome antibody array (System Biosciences). The array had eight positive markers (CD63, EpCAM: epithelial cell adhesion molecule, ANXA5: annexin A5, TSG101: tumor susceptibility gene 101, FLOT1: flotillin-1, ICAM: intercellular adhesion molecule 1, ALIX: programmed cell death 6 interacting protein, and CD81) and four controls including cis-golgi matrix protein (GM130) as a negative marker for cellular contamination during exosome isolation, two positive controls (+ ctrl), and a blank control. According to the manufacturer’s protocol, 50 µg DPSC-Exos suspended in PBS were mixed with 10% (v/v) lysis buffer and 1 µL labeling reagent. After 30 min incubation at room temperature (RT), the excess labeling reagent was removed using a column filter. A membrane was immersed in the mixture of labeled exosome lysate and 5 mL blocking buffer at 4 °C overnight on a shaker. After washing, the membrane was developed with WesternBright Sirius HRP substrate (Advansta, Menlo Park, CA, USA).

4.6. Scanning Electron Microscopy (SEM)

DPSC-Exos were fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate and loaded on a clean silicon wafer (Ted Pella, Redding, CA, USA) on the top of a 37 °C hotplate. The wafer was covered with 100% hexamethyldisilazane (Ted Pella) for 10 min and then washed with PBS. After drying overnight, the samples were mounted on an aluminum stub (Ted Pella) with double-sided carbon tape and processed for an iridium sputter coating (Q150R-S, Quorum Technologies, Laughton, UK) to make the surface conductive. The final product was imaged in a high-resolution SEM (S-4800, Hitachi High-Tech, Ibaraki, Japan).

4.7. Exosome Labeling and Cellular Uptake

DPSC-Exos were labeled with a PKH67 green lipid membrane dye (Sigma-Aldrich) according to the manufacturer’s instructions. Briefly, 5 × 108/mL exosomes suspended in 1 mL diluent C were mixed with 4 µL PKH67 and incubated for 5 min at room temperature. An equal volume of 5% bovine serum albumin was added to stop the labeling, and then the mixture was centrifuged with 110,000 g for 2 h at 4 °C. After washing with PBS and repeating centrifugation, the labeled exosomes were co-cultured with DPSCs for 48 h and imaged by an Olympus FV1000 confocal microscope (Olympus, Center Valley, PA, USA). Exosomes without PKH67 labeling were used for a negative control.

4.8. Cell Toxicity

DPSCs were seeded at a density of 1 × 104 (200 µL) in 96-well plates. The next day, the cells were treated with various concentrations of DPSC-Exos (Exo-L: 5 × 107/mL, Exo-M: 5 × 108/mL, or Exo-H: 5 × 109/mL) in a serum-free culture medium. Vehicle controls, 4.3%, 9.0%, and 16.3% (v/v) PBS, and no exosome treatment control, were prepared because the final products of exosomes were diluted in PBS. After 24 h, cytotoxicity was determined by CellTiter 96®Aqueous One Solution (Promega, Madison, WI, USA). One Solution Reagent (20 µL) was added into each well of the 96-well plates (100 µL medium), and the plates were incubated at 37 °C in a humidified incubator for 4 h. The absorbance was recorded at 490 nm using a 96-well plate reader (Infinite® 200 PRO, TECAN, Männedorf, Switzerland).

4.9. Cell Proliferation

The cells were seeded at a density of 1 × 104 (200 µL) in 48-well plates. After 2 h for cell adhesion, the media were replaced with 200 µL of treatment groups: controls (serum-free medium or serum-free medium with 10% exosomes-depleted FBS) and 5 × 107/mL or 5 × 108/mL DPSC-Exos (Exo-G or Exo-A). The media were changed every two days. At day 4, cell viability was evaluated using CellTiter 96®Aqueous One Solution (Promega).

4.10. Cell Migration

The cells (1 × 104/100 µL) were added to the polycarbonate membrane inserts of 24-well Transwell® plates with an 8 µm pore (Corning, Corning, NY, USA). In the reservoirs, 600 µL of serum-free medium or DPSC-Exos (5 × 107/mL and 5 × 108/mL Exo-G or Exo-A) were added. Following 48 h incubation, the inserts were swabbed with sterile cotton tips to remove non-migrated cells and washed twice in Hanks’ Balanced Salt Solution (HBSS). The inserts were stained with Calcein AM (1:1000 dilution; Thermo Fisher Scientific) and imaged by a confocal microscope. Separately, the migrated cells were digested in papain digestion buffer (1 mg/mL papain, 5 mM L-cysteine hydrochloride acid, 100 mM disodium hydrogen phosphate, 5 mM ethylenediaminetetraacetic acid salt) for 2 h and quantified using a Quant-iTTM PicoGreen® dsDNA Assay kit (Thermo Fisher Scientific). Fluorescence was measured on the plate reader at 480 nm excitation and 520 nm emission.

4.11. Angiogenic Differentiation

A total of six groups were prepared to evaluate the effect of DPSC-Exos on angiogenic differentiation: (1) basal angiogenic (bAM) differentiation medium without growth factors, (2) bAM + Exo-G, (3) bAM + Exo-A, (4) completed angiogenic (cAM) differentiation medium with growth factors, (5) cAM + Exo-G, and (6) cAM + Exo-A. DPSCs were seeded at a density of 3 × 105 (2 mL) in 6-well plates, and the medium with or without 5 × 108 DPSC-Exos was replaced every 2 days. After 7 days, the cells were trypsinized for gene expression analysis.

4.12. Real-Time Polymerase Chain Reaction (RT-PCR)

The cells were lysed to collect ribonucleic acid (RNA) using an RNAqueousTM Total RNA Isolation kit (Thermo Fisher Scientific) for reverse transcription. A qualitative and quantitative assessment of RNA samples was performed with a NanodropTM 2000 spectrophotometer (Thermo Fisher Scientific) prior to complementary deoxyribonucleic acid (cDNA) synthesis using a SuperScriptTM VILOTM cDNA Synthesis kit (Thermo Fisher Scientific). The TaqmanTM gene expression assay was performed using a QuantStudioTM 3 RT-PCR System (Applied Biosystems, Foster City, CA, USA) in a 10 µL PCR reaction mix containing 2 µL of cDNA template and an appropriate concentration of the TaqmanTM Advanced Master Mix and probes as recommended by the manufacturer. We used species-specific, premade probes (Thermo Fisher Scientific) labeled with a fluorescein (FAM) reporter and a minor groove binder (MGB) quencher both for housekeeping (GAPDH: Oc03823402_g1) and three target genes, vascular endothelial growth factor A (VEGFA: Oc03395999_m1), Fms-related tyrosine kinase 1 (FLT1: Oc06783656_s1), and platelet and endothelial cell adhesion molecule 1 (PECAM1: Oc06726473_m1). The relative changes in gene expression levels were calculated by the comparative CT (∆∆CT) method [67].

4.13. Next-Generation Sequencing (NGS)

Two batches of rabbit DPSC-Exos were prepared for NGS analysis. Exosomal RNAs were extracted and quantified by a Bioanalyzer Small RNA Assay kit (Agilent, Santa Clara, CA, USA). NGS libraries were prepared and sequenced on a HiSeq® Sequencing System (Illumina, San Diego, CA, USA) with 150 bp paired-end reads at an approximate depth of 10-15 million reads per sample in System Biosciences. Raw data were analyzed in the Bioinformatics Division of the Iowa Institute of Human Genetics (IIHG). To quantitate known small RNAs and to identify novel miRNAs, we used the Nextflow-based workflow nf-core/smrnaseq (version v1.1.0, https://github.com/nf-core/smrnaseq) (Accessed on 27 April 2022) as a small-RNA sequencing analysis pipeline. Rabbit (Oryctolagus cuniculus, build oryCun2) genome sequence (fasta) and annotation (gff) were downloaded from Ensembl (http://ftp.ensembl.org/pub/release-100) (Accessed on 27 April 2022). Sequences for mature and hairpin small RNAs were downloaded from miRBase (https://www.mirbase.org/ftp/CURRENT/) (Accessed on 27 April 2022). The adaptor protocol used was ‘qiaseq’, but for all other parameters, the default values were used. In brief, the workflow uses FastQC for assessing read quality, Trim Galore! for adapter trimming, seqcluster for read collapsing, and Bowtie1 for aligning reads to small RNA sequences. Read counts were imported into R and normalized using DESeq2. To determine differential expression, a model incorporating all the experimental factors was created, and Wald tests were used to compute statistical metrics. A small RNA was considered to have a statistically significant change in expression if the False Discovery Rate (FDR) was less than 10%. Results from the differential expression analysis were visualized using a volcano plot created with the ggplot2 package in R. To identify novel miRNAs, sequence read files (fastq) from samples in the same group were first concatenated together and then ran through the same nf-core/smrnaseq workflow as above with the miRDeep2 software used for novel miRNA identification. The results from miRDeep2 were filtered to include only potential novel miRNAs with miRDeep2 scores greater than or equal to 4 (higher quality).

4.14. Statistics

The scatter plots were expressed as the mean values with the standard deviation using GraphPad Prism (Version 8.1.2; San Diego, CA, USA). Data were compared by one-way ANOVA with the Tukey post-hoc test using SPSS Statistics software (Version 28; IBM, Armonk, NY, USA). Statistical significance was set at p < 0.05.

5. Conclusions

This study was designed to evaluate the effects of stem cell-derived exosomes on cell homing and angiogenic lineage-specific differentiation for pulp regeneration. Our results showed that DPSC-Exos (both Exo-G and Exo-A) significantly promoted cell proliferation, migration, and angiogenic differentiation although there was no superior effect of Exo-A on angiogenic differentiation compared to Exo-G in this in vitro study. In addition, we identified key miRNAs which regulate cell homing and angiogenesis. Therefore, our exosome-based cell homing and angiogenic differentiation strategy has a significant therapeutic potential for dental pulp regeneration.

6. Patents

The authors declare that there is potential intellectual property regarding the publication of this article.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms24010466/s1.

Author Contributions

Conceptualization, D.S., K.S. and J.A.M.; methodology, V.G., D.S. and P.C.G.-C.; formal analysis, H.L.K.; data curation, V.G. and D.S.; writing—original draft preparation, V.G. and D.S.; writing—review and editing, P.C.G.-C., H.L.K., K.S. and J.A.M.; visualization, D.S.; supervision, D.S.; funding acquisition, D.S. All authors have read and agreed to the published version of the manuscript.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institute of Health (NIH) under award number 1R03DE030515-01.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors thank Chantal Allamargot for helping with SEM image acquisition, David Roman and Moana Hala’ufia for allowing our use of an ultracentrifuge, Douglas Fredericks and Emily Petersen for the donation of rabbit dental pulps, and Abigail Smith for invaluable administrative support.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Islam, B.; Khan, S.N.; Khan, A.U. Dental caries: From infection to prevention. Med. Sci. Monit. 2007, 13, RA196–RA203. [Google Scholar] [PubMed]
  2. Foreman, P.C.; Barnes, I.E. Review of calcium hydroxide. Int. Endod. J. 1990, 23, 283–297. [Google Scholar] [CrossRef] [PubMed]
  3. Mass, E.; Zilberman, U. Long-term radiologic pulp evaluation after partial pulpotomy in young permanent molars. Quintessence Int. 2011, 42, 547–554. [Google Scholar] [PubMed]
  4. Parirokh, M.; Torabinejad, M. Mineral trioxide aggregate: A comprehensive literature review—Part I: Chemical, physical, and antibacterial properties. J. Endod. 2010, 36, 16–27. [Google Scholar] [CrossRef]
  5. Torabinejad, M.; Parirokh, M. Mineral trioxide aggregate: A comprehensive literature review—Part II: Leakage and biocompatibility investigations. J. Endod. 2010, 36, 190–202. [Google Scholar] [CrossRef]
  6. Desai, S.; Chandler, N. Calcium hydroxide-based root canal sealers: A review. J. Endod. 2009, 35, 475–480. [Google Scholar] [CrossRef]
  7. Parirokh, M.; Torabinejad, M. Mineral trioxide aggregate: A comprehensive literature review—Part III: Clinical applications, drawbacks, and mechanism of action. J. Endod. 2010, 36, 400–413. [Google Scholar] [CrossRef]
  8. Ghoddusi, J.; Forghani, M.; Parisay, I. New approaches in vital pulp therapy in permanent teeth. Iran Endod. J. 2014, 9, 15–22. [Google Scholar]
  9. Ward, J. Vital pulp therapy in cariously exposed permanent teeth and its limitations. Aust. Endod. J. 2002, 28, 29–37. [Google Scholar] [CrossRef]
  10. Iohara, K.; Imabayashi, K.; Ishizaka, R.; Watanabe, A.; Nabekura, J.; Ito, M.; Matsushita, K.; Nakamura, H.; Nakashima, M. Complete pulp regeneration after pulpectomy by transplantation of CD105+ stem cells with stromal cell-derived factor-1. Tissue Eng. Part A 2011, 17, 1911–1920. [Google Scholar] [CrossRef]
  11. Ishizaka, R.; Iohara, K.; Murakami, M.; Fukuta, O.; Nakashima, M. Regeneration of dental pulp following pulpectomy by fractionated stem/progenitor cells from bone marrow and adipose tissue. Biomaterials 2012, 33, 2109–2118. [Google Scholar] [CrossRef] [PubMed]
  12. Xuan, K.; Li, B.; Guo, H.; Sun, W.; Kou, X.; He, X.; Zhang, Y.; Sun, J.; Liu, A.; Liao, L.; et al. Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth. Sci. Transl. Med. 2018, 10, eaaf3227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Mao, J.J.; Kim, S.G.; Zhou, J.; Ye, L.; Cho, S.; Suzuki, T.; Fu, S.Y.; Yang, R.; Zhou, X. Regenerative endodontics: Barriers and strategies for clinical translation. Dent. Clin. N. Am. 2012, 56, 639–649. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Eramo, S.; Natali, A.; Pinna, R.; Milia, E. Dental pulp regeneration via cell homing. Int. Endod. J. 2018, 51, 405–419. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Huang, G.T.; Gronthos, S.; Shi, S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: Their biology and role in regenerative medicine. J. Dent. Res. 2009, 88, 792–806. [Google Scholar] [CrossRef]
  16. Shi, X.; Mao, J.; Liu, Y. Concise review: Pulp stem cells derived from human permanent and deciduous teeth: Biological characteristics and therapeutic applications. Stem Cells Transl. Med. 2020, 9, 445–464. [Google Scholar] [CrossRef] [Green Version]
  17. Goldberg, M.; Farges, J.C.; Lacerda-Pinheiro, S.; Six, N.; Jegat, N.; Decup, F.; Septier, D.; Carrouel, F.; Durand, S.; Chaussain-Miller, C.; et al. Inflammatory and immunological aspects of dental pulp repair. Pharmacol. Res. 2008, 58, 137–147. [Google Scholar] [CrossRef] [Green Version]
  18. Lai, R.C.; Arslan, F.; Lee, M.M.; Sze, N.S.; Choo, A.; Chen, T.S.; Salto-Tellez, M.; Timmers, L.; Lee, C.N.; El Oakley, R.M.; et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010, 4, 214–222. [Google Scholar] [CrossRef] [Green Version]
  19. Tao, S.C.; Yuan, T.; Zhang, Y.L.; Yin, W.J.; Guo, S.C.; Zhang, C.Q. Exosomes derived from miR-140-5p-overexpressing human synovial mesenchymal stem cells enhance cartilage tissue regeneration and prevent osteoarthritis of the knee in a rat model. Theranostics 2017, 7, 180–195. [Google Scholar] [CrossRef]
  20. Tetta, C.; Consiglio, A.L.; Bruno, S.; Tetta, E.; Gatti, E.; Dobreva, M.; Cremonesi, F.; Camussi, G. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J. 2012, 2, 212–221. [Google Scholar]
  21. Zhang, B.; Wang, M.; Gong, A.; Zhang, X.; Wu, X.; Zhu, Y.; Shi, H.; Wu, L.; Zhu, W.; Qian, H.; et al. HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing. Stem Cells 2015, 33, 2158–2168. [Google Scholar] [CrossRef] [PubMed]
  22. Zhang, S.; Chu, W.C.; Lai, R.C.; Lim, S.K.; Hui, J.H.; Toh, W.S. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthr. Cartil. 2016, 24, 2135–2140. [Google Scholar] [CrossRef] [PubMed]
  23. Raposo, G.; Stoorvogel, W. Extracellular vesicles: Exosomes, microvesicles, and friends. J. Cell Biol. 2013, 200, 373–383. [Google Scholar] [CrossRef] [Green Version]
  24. He, L.; Zhang, H. MicroRNAs in the Migration of Mesenchymal Stem Cells. Stem Cell Rev. Rep. 2019, 15, 3–12. [Google Scholar] [CrossRef]
  25. Tao, S.C.; Guo, S.C.; Zhang, C.Q. Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach. Int. J. Biol. Sci. 2017, 13, 828–834. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Guo, S.C.; Tao, S.C.; Yin, W.J.; Qi, X.; Yuan, T.; Zhang, C.Q. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics 2017, 7, 81–96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Zhang, S.; Chuah, S.J.; Lai, R.C.; Hui, J.H.P.; Lim, S.K.; Toh, W.S. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials 2018, 156, 16–27. [Google Scholar] [CrossRef]
  28. Hu, X.; Zhong, Y.; Kong, Y.; Chen, Y.; Feng, J.; Zheng, J. Lineage-specific exosomes promote the odontogenic differentiation of human dental pulp stem cells (DPSCs) through TGFbeta1/smads signaling pathway via transfer of microRNAs. Stem Cell Res. Ther. 2019, 10, 170. [Google Scholar] [CrossRef] [Green Version]
  29. Ivica, A.; Ghayor, C.; Zehnder, M.; Valdec, S.; Weber, F.E. Pulp-Derived Exosomes in a Fibrin-Based Regenerative Root Filling Material. J. Clin. Med. 2020, 9, 491. [Google Scholar] [CrossRef] [Green Version]
  30. Stanko, P.; Altanerova, U.; Jakubechova, J.; Repiska, V.; Altaner, C. Dental Mesenchymal Stem/Stromal Cells and Their Exosomes. Stem Cells Int. 2018, 2018, 8973613. [Google Scholar] [CrossRef] [Green Version]
  31. Coughlan, C.; Bruce, K.D.; Burgy, O.; Boyd, T.D.; Michel, C.R.; Garcia-Perez, J.E.; Adame, V.; Anton, P.; Bettcher, B.M.; Chial, H.J.; et al. Exosome Isolation by Ultracentrifugation and Precipitation and Techniques for Downstream Analyses. Curr. Protoc. Cell Biol. 2020, 88, e110. [Google Scholar] [CrossRef] [PubMed]
  32. Thery, C.; Witwer, K.W.; Aikawa, E.; Alcaraz, M.J.; Anderson, J.D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G.K.; et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018, 7, 1535750. [Google Scholar] [CrossRef] [PubMed]
  33. Gurunathan, S.; Kang, M.H.; Jeyaraj, M.; Qasim, M.; Kim, J.H. Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells 2019, 8, 307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Yeo, R.W.; Lai, R.C.; Zhang, B.; Tan, S.S.; Yin, Y.; Teh, B.J.; Lim, S.K. Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Adv. Drug Deliv. Rev. 2013, 65, 336–341. [Google Scholar] [CrossRef] [PubMed]
  35. Gurung, S.; Perocheau, D.; Touramanidou, L.; Baruteau, J. The exosome journey: From biogenesis to uptake and intracellular signalling. Cell Commun. Signal. 2021, 19, 47. [Google Scholar] [CrossRef]
  36. Sung, B.H.; Parent, C.A.; Weaver, A.M. Extracellular vesicles: Critical players during cell migration. Dev. Cell 2021, 56, 1861–1874. [Google Scholar] [CrossRef]
  37. Maas, S.L.N.; Breakefield, X.O.; Weaver, A.M. Extracellular Vesicles: Unique Intercellular Delivery Vehicles. Trends Cell Biol. 2017, 27, 172–188. [Google Scholar] [CrossRef] [Green Version]
  38. Kriebel, P.W.; Majumdar, R.; Jenkins, L.M.; Senoo, H.; Wang, W.; Ammu, S.; Chen, S.; Narayan, K.; Iijima, M.; Parent, C.A. Extracellular vesicles direct migration by synthesizing and releasing chemotactic signals. J. Cell Biol. 2018, 217, 2891–2910. [Google Scholar] [CrossRef]
  39. Sung, B.H.; von Lersner, A.; Guerrero, J.; Krystofiak, E.S.; Inman, D.; Pelletier, R.; Zijlstra, A.; Ponik, S.M.; Weaver, A.M. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat. Commun. 2020, 11, 2092. [Google Scholar] [CrossRef]
  40. Jimenez, L.; Yu, H.; McKenzie, A.J.; Franklin, J.L.; Patton, J.G.; Liu, Q.; Weaver, A.M. Quantitative Proteomic Analysis of Small and Large Extracellular Vesicles (EVs) Reveals Enrichment of Adhesion Proteins in Small EVs. J. Proteome Res. 2019, 18, 947–959. [Google Scholar] [CrossRef]
  41. Hakulinen, J.; Sankkila, L.; Sugiyama, N.; Lehti, K.; Keski-Oja, J. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J. Cell Biochem. 2008, 105, 1211–1218. [Google Scholar] [CrossRef] [PubMed]
  42. Laghezza Masci, V.; Taddei, A.R.; Gambellini, G.; Giorgi, F.; Fausto, A.M. Microvesicles shed from fibroblasts act as metalloproteinase carriers in a 3-D collagen matrix. J. Circ. Biomark. 2016, 5, 1849454416663660. [Google Scholar] [CrossRef] [PubMed]
  43. Narayanan, R.; Huang, C.C.; Ravindran, S. Hijacking the Cellular Mail: Exosome Mediated Differentiation of Mesenchymal Stem Cells. Stem Cells Int. 2016, 2016, 3808674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Bronckaers, A.; Hilkens, P.; Fanton, Y.; Struys, T.; Gervois, P.; Politis, C.; Martens, W.; Lambrichts, I. Angiogenic properties of human dental pulp stem cells. PLoS ONE 2013, 8, e71104. [Google Scholar] [CrossRef] [Green Version]
  45. Hilkens, P.; Fanton, Y.; Martens, W.; Gervois, P.; Struys, T.; Politis, C.; Lambrichts, I.; Bronckaers, A. Pro-angiogenic impact of dental stem cells in vitro and in vivo. Stem Cell Res. 2014, 12, 778–790. [Google Scholar] [CrossRef] [Green Version]
  46. Sun, L.L.; Xiao, L.; Du, X.L.; Hong, L.; Li, C.L.; Jiao, J.; Li, W.D.; Li, X.Q. MiR-205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression. J. Cell Mol. Med. 2019, 23, 8493–8504. [Google Scholar] [CrossRef] [Green Version]
  47. Brunello, G.; Zanotti, F.; Trentini, M.; Zanolla, I.; Pishavar, E.; Favero, V.; Favero, R.; Favero, L.; Bressan, E.; Bonora, M.; et al. Exosomes Derived from Dental Pulp Stem Cells Show Different Angiogenic and Osteogenic Properties in Relation to the Age of the Donor. Pharmaceutics 2022, 14, 908. [Google Scholar] [CrossRef]
  48. Xie, K.; Cai, Y.; Yang, P.; Du, F.; Wu, K. Upregulating microRNA-874-3p inhibits CXCL12 expression to promote angiogenesis and suppress inflammatory response in ischemic stroke. Am. J. Physiol. Cell Physiol. 2020, 319, C579–C588. [Google Scholar] [CrossRef]
  49. Lu, G.D.; Cheng, P.; Liu, T.; Wang, Z. BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis. Front. Cell Dev. Biol. 2020, 8, 608521. [Google Scholar] [CrossRef]
  50. Yang, Z.; Wu, L.; Zhu, X.; Xu, J.; Jin, R.; Li, G.; Wu, F. MiR-29a modulates the angiogenic properties of human endothelial cells. Biochem. Biophys. Res. Commun. 2013, 434, 143–149. [Google Scholar] [CrossRef] [Green Version]
  51. Lee, A.; Papangeli, I.; Park, Y.; Jeong, H.N.; Choi, J.; Kang, H.; Jo, H.N.; Kim, J.; Chun, H.J. A PPARgamma-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis. Sci. Rep. 2017, 7, 2528. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Lei, Z.; Li, B.; Yang, Z.; Fang, H.; Zhang, G.M.; Feng, Z.H.; Huang, B. Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 2009, 4, e7629. [Google Scholar] [CrossRef] [PubMed]
  53. Ajay Sharma, L.; Love, R.M.; Ali, M.A.; Sharma, A.; Macari, S.; Avadhani, A.; Dias, G.J. Healing response of rat pulp treated with an injectable keratin hydrogel. J. Appl. Biomater. Funct. Mater. 2017, 15, e244–e250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Bader, A.G.; Brown, D.; Winkler, M. The promise of microRNA replacement therapy. Cancer Res. 2010, 70, 7027–7030. [Google Scholar] [CrossRef] [Green Version]
  55. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659. [Google Scholar] [CrossRef] [Green Version]
  56. Eulalio, A.; Mano, M.; Dal Ferro, M.; Zentilin, L.; Sinagra, G.; Zacchigna, S.; Giacca, M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492, 376–381. [Google Scholar] [CrossRef]
  57. Joris, V.; Gomez, E.L.; Menchi, L.; Lobysheva, I.; Di Mauro, V.; Esfahani, H.; Condorelli, G.; Balligand, J.L.; Catalucci, D.; Dessy, C. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium. Arterioscler. Thromb. Vasc. Biol. 2018, 38, 2345–2357. [Google Scholar] [CrossRef] [Green Version]
  58. Urbich, C.; Kuehbacher, A.; Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79, 581–588. [Google Scholar] [CrossRef] [Green Version]
  59. Nicoli, S.; Knyphausen, C.P.; Zhu, L.J.; Lakshmanan, A.; Lawson, N.D. miR-221 is required for endothelial tip cell behaviors during vascular development. Dev. Cell 2012, 22, 418–429. [Google Scholar] [CrossRef] [Green Version]
  60. Sun, X.; Song, W.; Teng, L.; Huang, Y. MiRNA 24-3p-rich exosomes functionalized DEGMA-modified hyaluronic acid hydrogels for corneal epithelial healing. Bioact. Mater. 2022; in press. [Google Scholar] [CrossRef]
  61. Ma, S.; Zhang, A.; Li, X.; Zhang, S.; Liu, S.; Zhao, H.; Wu, S.; Chen, L.; Ma, C.; Zhao, H. MiR-21-5p regulates extracellular matrix degradation and angiogenesis in TMJOA by targeting Spry1. Arthritis Res. Ther. 2020, 22, 99. [Google Scholar] [CrossRef]
  62. Xie, J.; Wu, W.; Zheng, L.; Lin, X.; Tai, Y.; Wang, Y.; Wang, L. Roles of MicroRNA-21 in Skin Wound Healing: A Comprehensive Review. Front. Pharmacol. 2022, 13, 828627. [Google Scholar] [CrossRef]
  63. Deng, S.; Zhao, Q.; Zhen, L.; Zhang, C.; Liu, C.; Wang, G.; Zhang, L.; Bao, L.; Lu, Y.; Meng, L.; et al. Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents. Theranostics 2017, 7, 1953–1965. [Google Scholar] [CrossRef] [PubMed]
  64. Sun, D.G.; Xin, B.C.; Wu, D.; Zhou, L.; Wu, H.B.; Gong, W.; Lv, J. miR-140-5p-mediated regulation of the proliferation and differentiation of human dental pulp stem cells occurs through the lipopolysaccharide/toll-like receptor 4 signaling pathway. Eur. J. Oral Sci. 2017, 125, 419–425. [Google Scholar] [CrossRef] [PubMed]
  65. Yin, K.; Wang, S.; Zhao, R.C. Exosomes from mesenchymal stem/stromal cells: A new therapeutic paradigm. Biomark. Res. 2019, 7, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Zayed, M.; Iohara, K.; Watanabe, H.; Ishikawa, M.; Tominaga, M.; Nakashima, M. Characterization of stable hypoxia-preconditioned dental pulp stem cells compared with mobilized dental pulp stem cells for application for pulp regenerative therapy. Stem Cell Res. Ther. 2021, 12, 302. [Google Scholar] [CrossRef] [PubMed]
  67. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
Ijms 24 00466 g001 550
Figure 1. Characterization of rabbit dental pulp stem cells (DPSCs) and DPSC-derived exosomes (DPSC-Exos). (A,B) Tube formation as a marker of angiogenesis from DPSCs cultured in a regular medium (A) or angiogenic induction medium for 10 days (B). (C,D) Alizarin Red S staining as a marker of osteogenesis in osteogenic induction medium at 10 (C) and 20 (D) days. Exosomes were isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A). (E) Average size and concentration of Exo-G and Exo-A via Nanoparticle Tracking Analyzer (NTA). Red error bars indicate ± standard error of the mean (n = 3) (F) Exosome antibody array having eight positive markers (CD63, EpCAM: epithelial cell adhesion molecule, ANXA5: annexin A5, TSG101: tumor susceptibility gene 101, FLOT1: flotillin-1, ICAM: intercellular adhesion molecule 1, ALIX: programmed cell death 6 interacting protein, and CD81) and four controls including cis-golgi matrix protein (GM130) as a negative marker for cellular contamination during exosome isolation, two positive controls (+ Ctrl), and a blank control (Blank). (G,H) Scanning electron microscopy (SEM) images of Exo-G (G) and Exo-A (H). (I,J) Cellular uptake of Exo-G (I) and Exo-A (J) using PKH67 green fluorescence.
Figure 1. Characterization of rabbit dental pulp stem cells (DPSCs) and DPSC-derived exosomes (DPSC-Exos). (A,B) Tube formation as a marker of angiogenesis from DPSCs cultured in a regular medium (A) or angiogenic induction medium for 10 days (B). (C,D) Alizarin Red S staining as a marker of osteogenesis in osteogenic induction medium at 10 (C) and 20 (D) days. Exosomes were isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A). (E) Average size and concentration of Exo-G and Exo-A via Nanoparticle Tracking Analyzer (NTA). Red error bars indicate ± standard error of the mean (n = 3) (F) Exosome antibody array having eight positive markers (CD63, EpCAM: epithelial cell adhesion molecule, ANXA5: annexin A5, TSG101: tumor susceptibility gene 101, FLOT1: flotillin-1, ICAM: intercellular adhesion molecule 1, ALIX: programmed cell death 6 interacting protein, and CD81) and four controls including cis-golgi matrix protein (GM130) as a negative marker for cellular contamination during exosome isolation, two positive controls (+ Ctrl), and a blank control (Blank). (G,H) Scanning electron microscopy (SEM) images of Exo-G (G) and Exo-A (H). (I,J) Cellular uptake of Exo-G (I) and Exo-A (J) using PKH67 green fluorescence.
Ijms 24 00466 g001
Ijms 24 00466 g002 550
Figure 2. The effect of dental pulp stem cells-derived exosomes (DPSC-Exos) on cell toxicity, proliferation, and migration. Exosomes were isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A) and used at a concentration of 5 × 107/mL (Exo-G-L or Exo-A-L), 5 × 108/mL (Exo-G-M or Exo-A-M), or 5 × 109/mL (Exo-G-H or Exo-A-H). (A) Cytotoxicity at 24 h (n = 4–16). (B) Cell proliferation at 4 days (n = 6). (C) Representative confocal images of migrated cells. FBS: fetal bovine serum. Green: Calcein AM. Scale bar: 200 µm. (D) Quantified fluorescence for cell migration (n = 3).
Figure 2. The effect of dental pulp stem cells-derived exosomes (DPSC-Exos) on cell toxicity, proliferation, and migration. Exosomes were isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A) and used at a concentration of 5 × 107/mL (Exo-G-L or Exo-A-L), 5 × 108/mL (Exo-G-M or Exo-A-M), or 5 × 109/mL (Exo-G-H or Exo-A-H). (A) Cytotoxicity at 24 h (n = 4–16). (B) Cell proliferation at 4 days (n = 6). (C) Representative confocal images of migrated cells. FBS: fetal bovine serum. Green: Calcein AM. Scale bar: 200 µm. (D) Quantified fluorescence for cell migration (n = 3).
Ijms 24 00466 g002
Ijms 24 00466 g003 550
Figure 3. The effect dental pulp stem cells-derived exosomes (DPSC-Exos) on angiogenic differentiation. Exosomes (5 × 108/mL) isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A) were treated in either basal or complete angiogenic induction medium (bAM or cAM) (n = 4). Control: no exosome treatment. VEGFA: vascular endothelial growth factor A, FLT1: Fms-related tyrosine kinase 1 (known as VEGF receptor 1), and PECAM1: platelet and endothelial cell adhesion molecule 1.
Figure 3. The effect dental pulp stem cells-derived exosomes (DPSC-Exos) on angiogenic differentiation. Exosomes (5 × 108/mL) isolated from DPSCs cultured under a growth (Exo-G) or angiogenic differentiation condition (Exo-A) were treated in either basal or complete angiogenic induction medium (bAM or cAM) (n = 4). Control: no exosome treatment. VEGFA: vascular endothelial growth factor A, FLT1: Fms-related tyrosine kinase 1 (known as VEGF receptor 1), and PECAM1: platelet and endothelial cell adhesion molecule 1.
Ijms 24 00466 g003
Ijms 24 00466 g004 550
Figure 4. MicroRNA (miRNA) profiling of rabbit (Oryctolagus cuniculus: ocu) dental pulp stem cells-derived exosomes (DPSC-Exos) via next-generation sequencing (NGS). Exosomes were isolated from DPSCs cultured under growth (Exo-G) or angiogenic differentiation conditions (Exo-A). (A) Mature miRNAs with over 10,000 total read counts in Exo-G. (B) Mature miRNAs with over 10,000 total read counts in Exo-A. (C) Mature miRNAs with over 10,000 total read counts in both Exo-G and Exo-A. (D) Volcano plot of Exo-A versus Exo-G. Red: significantly up/down-expressed miRNAs. (E) The number of identified miRNAs.
Figure 4. MicroRNA (miRNA) profiling of rabbit (Oryctolagus cuniculus: ocu) dental pulp stem cells-derived exosomes (DPSC-Exos) via next-generation sequencing (NGS). Exosomes were isolated from DPSCs cultured under growth (Exo-G) or angiogenic differentiation conditions (Exo-A). (A) Mature miRNAs with over 10,000 total read counts in Exo-G. (B) Mature miRNAs with over 10,000 total read counts in Exo-A. (C) Mature miRNAs with over 10,000 total read counts in both Exo-G and Exo-A. (D) Volcano plot of Exo-A versus Exo-G. Red: significantly up/down-expressed miRNAs. (E) The number of identified miRNAs.
Ijms 24 00466 g004
Table
Table 1. List of significantly up/down-expressed mature microRNAs (miRNAs): Exo-A versus Exo-G.
Table 1. List of significantly up/down-expressed mature microRNAs (miRNAs): Exo-A versus Exo-G.
miRNAlog2(Fold Change)p-ValuemiRNAlog2(Fold Change)p-Value
ocu-miR-708-5p5.060.0000ocu-miR-146a-5p−2.730.0000
ocu-miR-205-5p4.240.0000ocu-miR-503-5p−2.690.0000
ocu-miR-708-3p4.030.0000ocu-miR-20b-5p−2.630.0005
ocu-miR-885-5p3.850.0000ocu-miR-18a-3p−1.970.0003
ocu-miR-24-2-5p3.240.0000ocu-miR-18a-5p−1.920.0003
ocu-miR-29c-3p3.070.0000ocu-miR-122-5p−1.910.0223
ocu-let-7i-3p3.040.0001ocu-miR-421-3p−1.810.0019
ocu-miR-574-3p2.920.0000ocu-miR-350-5p−1.720.0099
ocu-miR-874-3p2.880.0000ocu-miR-1307-3p−1.690.0013
ocu-miR-134-5p2.500.0003ocu-miR-98-5p−1.680.0004
ocu-miR-125b-5p2.200.0000ocu-miR-432-5p−1.640.0147
ocu-miR-34c-3p2.060.0006ocu-miR-100-5p−1.600.0005
ocu-miR-140-3p1.990.0002ocu-miR-34a-5p−1.580.0094
ocu-miR-342-3p1.900.0000ocu-miR-16b-5p−1.510.0008
ocu-miR-145-5p1.820.0008ocu-miR-20a-5p−1.500.0271
ocu-miR-150-5p1.630.0053ocu-miR-30a-5p−1.460.0004
ocu-miR-148a-5p1.610.0251ocu-miR-93-5p−1.380.0238
ocu-miR-532-3p1.520.0065ocu-miR-6529-5p−1.370.0045
ocu-miR-30b-5p1.500.0046ocu-miR-143-3p−1.370.0104
ocu-miR-31-5p1.400.0044ocu-miR-652-3p−1.360.0241
ocu-miR-214-5p1.370.0031ocu-miR-574-5p−1.330.0123
ocu-miR-222-3p1.370.0010ocu-miR-7a-5p−1.320.0047
ocu-miR-323a-3p1.340.0082ocu-miR-151-3p−1.260.0102
ocu-miR-502a-3p1.210.0126ocu-miR-15b-3p−1.230.0097
ocu-miR-130a-3p1.210.0185ocu-miR-671-5p−1.210.0101
ocu-miR-12092-3p1.200.0055ocu-let-7f-5p−1.090.0268
ocu-miR-29b-3p1.130.0128ocu-let-7a-5p−1.080.0220
ocu-miR-29a-3p1.100.0216ocu-miR-423-5p−1.060.0259
ocu-miR-335-5p1.070.0174ocu-miR-125b-3p−1.060.0146
ocu-miR-181b-5p1.070.0143ocu-miR-361-5p−1.040.0240
ocu-miR-128a-3p−1.040.0161
ocu-miR-128b-3p−1.040.0161
Table
Table 2. List of significantly up/down-expressed hairpin microRNAs (miRNAs): Exo-A versus Exo-G. * Significant expression of both mature and hairpin miRNAs.
Table 2. List of significantly up/down-expressed hairpin microRNAs (miRNAs): Exo-A versus Exo-G. * Significant expression of both mature and hairpin miRNAs.
miRNAlog2(Fold Change)p-ValuemiRNAlog2(Fold Change)p-Value
ocu-mir-708 *6.700.0000ocu-mir-574 *−3.050.0007
ocu-mir-134 *3.060.0001ocu-mir-503 *−2.680.0000
ocu-mir-125b-2 *2.650.0000ocu-mir-590−2.310.0133
ocu-mir-140 *2.240.0000ocu-mir-30a *−1.940.0001
ocu-mir-29b-2 *2.040.0006ocu-mir-146a *−1.930.0041
ocu-mir-29b-1 *1.950.0011ocu-mir-671 *−1.770.0014
ocu-mir-214 *1.540.0003ocu-mir-181b-2−1.490.0112
ocu-mir-26a1.350.0013ocu-mir-152−1.380.0106
ocu-mir-23b1.050.0132ocu-mir-155−1.130.0104
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ganesh, V.; Seol, D.; Gomez-Contreras, P.C.; Keen, H.L.; Shin, K.; Martin, J.A. Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration. Int. J. Mol. Sci. 2023, 24, 466. https://doi.org/10.3390/ijms24010466

AMA Style

Ganesh V, Seol D, Gomez-Contreras PC, Keen HL, Shin K, Martin JA. Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration. International Journal of Molecular Sciences. 2023; 24(1):466. https://doi.org/10.3390/ijms24010466

Chicago/Turabian Style

Ganesh, Venkateswaran, Dongrim Seol, Piedad C. Gomez-Contreras, Henry L. Keen, Kyungsup Shin, and James A. Martin. 2023. "Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration" International Journal of Molecular Sciences 24, no. 1: 466. https://doi.org/10.3390/ijms24010466

APA Style

Ganesh, V., Seol, D., Gomez-Contreras, P. C., Keen, H. L., Shin, K., & Martin, J. A. (2023). Exosome-Based Cell Homing and Angiogenic Differentiation for Dental Pulp Regeneration. International Journal of Molecular Sciences, 24(1), 466. https://doi.org/10.3390/ijms24010466

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop